Sinopharm finally publishes Covid-19 vaccine trial data: interim Phase 3 results suggest two products have efficacy rates well above 50 per cent but there is little data on the elderly and other vulnerable groups

https://ift.tt/3ia82Gv via /r/worldnews https://ift.tt/3yM4csE